Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis.

M Arora1, R Arora, S C Tiwari

  • 1Department of Biochemistry, All India Institute of Medical Sciences, New Delhi. arora_meenakshi@hotmail.com

Lupus
|April 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined cyclosporine A and urolithin A therapy ameliorates murine lupus nephritis.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

THE SALMONID ONCORHYNCHUS MYKISS AND BRYOZOAN FREDERICELLA BOREALIS SERVE AS ACTIVE HOSTS FOR THE NORTH AMERICAN STRAIN OF TETRACAPSULOIDES BRYOSALMONAE, THE CAUSE OF PROLIFERATIVE KIDNEY DISEASE.

The Journal of parasitology·2026
Same author

Pathogenic Role of mTOR Signaling in Cardiometabolic Disease: Implications for Heart, Liver, and Kidney Dysfunction.

Physiological research·2025
Same author

Evidence based recommendations for health professionals to improve care of people with spinal cord injury and cognitive impairment: an update to the psychosocial care practice guide.

Spinal cord·2025
Same author

A Risk Profile Calculator for Anterior Cruciate Ligament (ACL) Reconstruction Surgery using a Novel Scoring System: The Multi-factorial ACL Target Score (MATS) Score.

Malaysian orthopaedic journal·2025
Same author

Lymph Node-Targeted Cyclosporine A Alleviates Myocarditis in Lupus Mice by Inhibiting CD68+ Macrophage-Driven Lymphangiogenesis.

Materials today (Kidlington, England)·2025

Systemic lupus erythematosus (SLE) patients with diffuse proliferative glomerulonephritis (DPGN) show reduced complement receptor 1 (CR1) on red blood cells and kidneys. However, increased decay accelerating factor (DAF) and CD59 suggest a protective response against complement damage.

Area of Science:

  • Nephrology
  • Immunology
  • Rheumatology

Background:

  • Diffuse proliferative glomerulonephritis (DPGN) is a severe manifestation of systemic lupus erythematosus (SLE).
  • The complement system plays a critical role in the pathogenesis of lupus nephritis.
  • Complement regulatory proteins on erythrocytes and glomerular cells may influence disease severity.

Purpose of the Study:

  • To investigate the expression of complement receptor 1 (CR1), decay accelerating factor (DAF), and membrane inhibitor of reactive lysis (CD59) in DPGN patients with SLE.
  • To elucidate the role of these complement regulatory proteins in the pathogenesis of DPGN.

Main Methods:

  • Flow cytometry and immunofluorescence techniques were employed.
  • Erythrocytes and glomerular tissues from DPGN patients and normal subjects were analyzed.

Related Experiment Videos

  • Expression levels of CR1, DAF, and CD59 were quantified.

    • Main Results:

    • Reduced expression of CR1 was observed on erythrocytes and glomeruli of DPGN patients compared to normal subjects.
    • Increased expression of DAF and CD59 was found on erythrocytes and glomeruli of DPGN patients.
    • These findings suggest a compensatory protective response against complement-mediated injury.

    Conclusions:

    • Alterations in complement regulatory protein expression (CR1, DAF, CD59) are characteristic of DPGN in SLE.
    • The observed increase in DAF and CD59 may represent an endogenous protective mechanism against complement-mediated glomerular damage.
    • Further research is warranted to explore therapeutic strategies targeting complement regulation in lupus nephritis.